Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin

Luis A. Marcos; Bernard C. Camins

doi:10.1128/AAC.00857-10

Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin

Luis A. Marcos
, Bernard C. Camins

Infectious Diseases

Washington University St. Louis

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.

Original language	English
Pages (from-to)	5376-5378
Number of pages	3
Journal	Antimicrobial Agents and Chemotherapy
Volume	54
Issue number	12
DOIs	https://doi.org/10.1128/AAC.00857-10
State	Published - Dec 2010

Access to Document

10.1128/AAC.00857-10

Cite this

@article{6eace54a96b240138c7f0c66b0c43d9e,

title = "Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin",

abstract = "Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.",

author = "Marcos, \{Luis A.\} and Camins, \{Bernard C.\}",

year = "2010",

month = dec,

doi = "10.1128/AAC.00857-10",

language = "English",

volume = "54",

pages = "5376--5378",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

number = "12",

}

TY - JOUR

T1 - Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin

AU - Marcos, Luis A.

AU - Camins, Bernard C.

PY - 2010/12

Y1 - 2010/12

N2 - Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.

AB - Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.

UR - https://www.scopus.com/pages/publications/78649688378

U2 - 10.1128/AAC.00857-10

DO - 10.1128/AAC.00857-10

M3 - Article

C2 - 20876369

AN - SCOPUS:78649688378

SN - 0066-4804

VL - 54

SP - 5376

EP - 5378

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 12

ER -

Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin

Abstract

Access to Document

Other files and links

Fingerprint

Cite this